Anxiolytic drug targets: beyond the usual suspects
J. Clin. Invest. 110:7 doi:10.1172/JCI16846
[Go to this article.]
Options: View larger image (or click on image)
Medium
Figure 1

In PKCε knockouts, the GABAA receptor has enhanced sensitivity to neurosteroids, resulting in increased Cl conductance when activated by both GABA and endogenous neurosteroids. PKCε knockouts also have reduced anxiety-like behavior, suggesting that PKCε deficiency leads to decreased anxiety by making the GABAA receptor more sensitive to the anxiolytic action of endogenous compounds such as neurosteroids.